Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31,604,526
-
Number of holders
-
140
-
Total 13F shares, excl. options
-
39,011,062
-
Shares change
-
-16,962
-
Total reported value, excl. options
-
$812,260,717
-
Value change
-
+$4,160,811
-
Put/Call ratio
-
33%
-
Number of buys
-
52
-
Number of sells
-
-81
-
Price
-
$20.82
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q3 2020
166 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q3 2020.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39,011,062 shares
.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (5,122,359 shares), BlackRock Inc. (2,808,684 shares), EVENTIDE ASSET MANAGEMENT, LLC (2,427,976 shares), PERCEPTIVE ADVISORS LLC (2,058,068 shares), Camber Capital Management LP (2,000,000 shares), Camber Capital Management LP (2,000,000 shares), Rubric Capital Management LP (1,926,283 shares), VANGUARD GROUP INC (1,672,630 shares), FRANKLIN RESOURCES INC (1,665,795 shares), and RENAISSANCE TECHNOLOGIES LLC (1,430,418 shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.